Is there any difference in target intraocular pressure for exfoliative glaucoma patients with cardiovascular disease history?

European Journal of Ophthalmology

Volumn 20, Issue 6, 2010, Pages 1000-1006

  Holló, Gábor ^a,b   Cvenkel, Barbara ^c   Teus, Miguel A ^k   Irkec, Murat T ^d   Astakhov, Yuri S ^e   Chiselita, Dorin ^f   Petkova, Nataliya ^g   Liehneová, Ivana ^h   Kaluzny, Bartlomiej J ⁱ   Kóthy, Péter ^a,b   Bozkurt, Banu ^d   Akopov, Evgeny L ^e   Stewart, Jeanette A ^j   Kristoffersen, Michael S ^j   Kristoffersen, Caroline J ^j   Stewart, William C ^j  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c UNIVERSITY OF ALCALÁ   (Spain)

^d HACETTEPE UNIVERSITY   (Turkey)

^e PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

^f Department of Biophysics and Radiopharmacy   (Romania)

^g MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^h Masaryk   (Czech Republic)

ⁱ NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^j University of South Carolina   (United States)

^k NONE

more..

Author keywords

Cardiovascular disease; Exfoliation glaucoma; Progression; Target intraocular pressure; Treatment goal

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EUROPE; EXFOLIATIVE GLAUCOMA; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; TRABECULECTOMY; TRABECULOPLASTY;

EID: 78650091976     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067211002000620     Document Type: Article

References (37)

1. Ritch R, Schlötzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol 2001; 45: 265-315.
2. Ritch R, Schlötzer-Schrehardt U, Konstas AG. Why is exfoliation syndrome associated with glaucoma? Prog Retin Eye Res 2003; 22: 253-75.
3. Vesti E, Kivela T. Exfoliation syndrome and exfoliation glaucoma. Prog Retin Eye Res 2000; 19: 345-68.
4. Konstas AG, Mantziris DA, Stewart WC. Diurnal intraocular pressure in untreated exfoliation and primary open-angle glaucoma. Arch Ophthalmol 1997; 115: 182-5.
5. Brooks AM, Gillies WE. The presentation and prognosis of glaucoma in pseudoexfoliation of the lens capsule. Ophthalmology 1988; 95: 271-6. (Pubitemid 18057884)
6. Blika S, Saunte E. Timolol maleate in the treatment of glaucoma simplex and glaucoma capsulare. Acta Ophthalmol (Copenh) 1982; 60: 967-76. (Pubitemid 13254839)
7. Pohjanpelto P. Influence of exfoliation syndrome on prognosis in ocular hypertension. Acta Ophthalmol (Copenh) 1986; 64: 39-44.
8. Konstas AG, Hollo G, Astakhov YS, et al. Factors associated with long-term progression or stability in exfoliation glaucoma. Arch Ophthalmol 2004; 122: 29-33. (Pubitemid 38063601)
9. European Glaucoma Society. Terminology and Guidelines for Glaucoma, 3rd ed. Savona: Editrice Dogma S.r.l.; 2008.
10. Visontai Z, Mersich B, Kollai M, Holló G. Increase of carotid artery stiffness and decrease of baroreflex sensitivity in exfoliation syndrome and glaucoma. Br J Ophthalmol 2006; 90: 563-7.
11. Visontai Z, Horváth T, Kollai M, Holló G. Decreased cardiovagal regulation in exfoliation syndrome. J Glaucoma 2008; 17: 133-8. (Pubitemid 351412403)
12. Bojic L, Ermacora R, Polic S, et al. Pseudoexfoliation syndrome and asymptomatic myocardial dysfunction. Graefes Arch Clin Exp Ophthalmol 2005; 243: 446-9. (Pubitemid 40823218)
13. Ritch R, Shields MB, Krupin T, eds. The Glaucomas, 2nd ed. St. Louis: Mosby; 1996: 255-97.
14. Stewart WC. Clinical Practice of Glaucoma. Thorofare: SLACK; 1990: 1-40, 149-96.
15. Holló G, Konstas AG. Is exfoliation syndrome a systemic disease? In: Holló G, Konstas AG, eds. Exfoliation Syndrome and Exfoliative Glaucoma. Savona: Dogma S.r.l.; 2008: 87-93.
16. Book SA. Essentials of Statistics. New York: McGraw-Hill Book Company; 1978: 122, 205.
17. Swinscow TD. Statistics at Square One. London: British Medical Association; 1976: 54-7.
18. Moses LE, Emerson JD, Hosseini H. Statistics in practice: analyzing data from ordered categories. N Engl J Med 1984; 311: 442-8. (Pubitemid 14058256)
19. Stewart WC, Chorak RP, Hunt HH, Sethuraman G. Factors associated with visual loss in patients with advanced glaucomatous changes in the optic nerve head. Am J Ophthalmol 1993; 116: 176-81. (Pubitemid 23229078)
20. Stewart WC, Kolker AE, Sharpe ED, et al. Factors associated with long-term progression or stability in primary open-angle glaucoma. Am J Ophthalmol 2000; 130: 274-9.
21. The AGIS Investigators. The advanced glaucoma intervention study (AGIS): 7: the relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000; 130: 429-40.
22. Quigley HA, Maumenee AE. Long-term follow-up of treated open-angle glaucoma. Am J Ophthalmol 1979; 87: 519-25. (Pubitemid 9125609)
23. Kolker AE. Visual prognosis in advanced glaucoma: a comparison of medical and surgical therapy for retention of vision in 101 eyes with advanced glaucoma. Trans Am Ophthalmol Soc 1977; 75: 539-55. (Pubitemid 8335230)
24. Odberg T. Visual field prognosis in advanced glaucoma. Acta Ophthalmol (Copenh) 1987; 65: 27-9. (Pubitemid 18028373)
25. Schulzer M, Mikelberg FS, Drance SM. Some observations on the relation between intraocular pressure reduction and the progression of glaucomatous visual loss. Br J Ophthalmol 1987; 71: 486-8. (Pubitemid 17093760)
26. Grant WM, Burke JF. Why do some people go blind from glaucoma? Ophthalmology 1982; 89: 991-8.
27. Stewart WC, Sine CS, Lo Presto C. Surgical versus medical management of chronic open-angle glaucoma. Am J Ophthalmol 1996; 122: 767-74. (Pubitemid 26412422)
28. Stewart WC, Kolker AE, Sharpe ED, et al. Long-term progression at individual mean intraocular pressure levels with primary open-angle and exfoliative glaucoma patients. Eur J Ophthalmol 2008; 18: 765-70.
29. Mao LK, Stewart WC, Shields MB. Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma. Am J Ophthalmol 1991; 111: 51-5.
30. Sommer A, Tielsch JM, Katz J, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. Arch Ophthalmol 1991; 109: 1090-5.
31. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 1998; 126: 487-97.
32. Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology. 2007; 114: 1965-72. (Pubitemid 350016362)
33. Leske MC, Connell AM, Wu SY, et al. Incidence of open-angle glaucoma: the Barbados Eye Studies. Arch Ophthalmol 2001; 119: 89-95. (Pubitemid 32096390)
34. Topouzis F, Coleman AL, Harris A, et al. Association of blood pressure status with the optic disk structure in non-glaucoma subjects: the Thessaloniki eye study. Am J Ophthalmol 2006; 142: 60-7.
35. Galassi F, Giambene B, Menchini U. Ocular perfusion pressure and retrobulbar haemodynamics in pseudoexfoliative glaucoma. Graefes Arch Clin Exp Ophthalmol 2008; 246: 411-6.
36. Ringvold A, Blika S, Sandvik L. Pseudo-exfoliation and mortality. Acta Ophthalmol Scand 1997; 75: 255-6.
37. Konstas AGP, Hollo G, Astakhov YS, et al. Presentation and long-term follow-up of exfoliation glaucoma in Greece, Spain, Russia and Hungary. Eur J Ophthalmol 2006; 16: 60-6.